LI Duofu;WU Cailiang;DU Jing;CUI Xueli. Studies on the value of human serum levels of human epididymis protein 4 in patients with gynecological pelvic lesions[J]. , 2012, 27(3): 202-205.
[1]Hellstrom I,Raycraft J,Hayden-Ledbetter M,et al.The HE4(WFDC2)protein is a biomarker for ovarian carcinoma [J].Cancer Res,2003,63(13):3695-3700.[2]Moore RG,Brown AK,Miller MC,et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass[J].Gynecol Oncol,2008,108(2):402-408.[3]Drapkin R, von Horsten HH, Lin Y, et al. Human epididymis protein 4(HE4)is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas[J]. Cancer Res,2005,65(6):2162-2169.[4]卢仁泉,郭 林,胡 娟.人附睾上皮分泌蛋白4在卵巢癌诊治中的应用价值[J].中华检验医学杂志,2009,32(12):1379-1383.[5]刘亚南,叶 雪,程洪艳,等.人附睾分泌蛋白4联合CA125在卵巢恶性肿瘤与子宫内膜异位症鉴别诊断中的价值[J]. 中华妇产科杂志,2010,45(5):363-366.[6]胡晓舟,崔丽艳,张 捷.健康人群血清HE4水平参考区间的初步探讨[J].中华检验医学杂志,2009,32(12):1376-1378.[7]Moore RG, Brown AK, Miller MC, et al. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus[J].Gynecol Oncol,2008,110(2):196-201.[8]Komai K,Nishida T.Tumor marker in ovarian cancer[J]. Gan To Kagaku Ryoho,2002,29(3):481-486.